We are live on ! Find out more
NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

18 hedge funds and large institutions have $3.49M invested in NewAmsterdam Pharma Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% more ownership

Funds ownership: 1.83% → 1.9% (+0.08%)

0% more funds holding

Funds holding: 18 → 18 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

26% less capital invested

Capital invested by funds: $4.73M → $3.49M (-$1.24M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
1
Calls
$143K
Puts
–
Net Calls
+$143K
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
AAA
Affinity Asset Advisors
New York
+$194K
2
UBS Group
UBS Group
Switzerland
+$74

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$26K
2
ETH
Exos TFP Holdings
New York
-$19.4K
3
Walleye Capital
Walleye Capital
New York
-$18.6K
4
Walleye Trading
Walleye Trading
New York
-$10.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$951K – – –
RCM
2
RA Capital Management
Massachusetts
$633K – – –
EC
3
EcoR1 Capital
California
$617K – – –
AAA
4
Affinity Asset Advisors
New York
$260K +$194K +100,000 +270%
Ensign Peak Advisors
5
Ensign Peak Advisors
Utah
$255K – – –
BCLSI
6
Bain Capital Life Sciences Investors
Massachusetts
$190K – – –
DM
7
Deerfield Management
New York
$176K – – –
HCM
8
Highbridge Capital Management
New York
$92.1K – – –
HF
9
HRT Financial
New York
$57K – – –
WCMNY
10
Westchester Capital Management (New York)
New York
$54.6K – – –
Walleye Capital
11
Walleye Capital
New York
$43K -$18.6K -9,600 -30%
PI
12
PEAK6 Investments
Illinois
$32.3K – – –
LCM
13
Laurion Capital Management
New York
$31.7K – – –
CS
14
Clear Street
New York
$25.6K – – –
Walleye Trading
15
Walleye Trading
New York
$24.9K -$10.5K -5,400 -29%
ETH
16
Exos TFP Holdings
New York
$23.3K -$19.4K -10,000 -45%
VI
17
Vestcor Inc
New Brunswick, Canada
$18K – – –
CG
18
Cutler Group
California
$9K – – –
UBS Group
19
UBS Group
Switzerland
$72 +$74 +38 New
WAM
20
Wolverine Asset Management
Illinois
– -$26K -12,448 Closed

NAMSW Hedge Fund Activity: Q3 2023 in Review

18 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q3 2023, worth a combined $3.49M — down 26% from $4.73M a quarter earlier.

Fund positioning in NAMSW was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Affinity Asset Advisors, adding an estimated $194K. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $26K sold.

  • 18 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $3.49M of NewAmsterdam Pharma Warrant stock for Q3 2023, down 26% quarter-over-quarter.
  • 1 fund opened new NewAmsterdam Pharma Warrant positions in Q3 2023 and 1 closed out, a net change of 0 holders.
  • The largest NewAmsterdam Pharma Warrant buyer in Q3 2023 was Affinity Asset Advisors, an estimated $194K added.
  • The largest NewAmsterdam Pharma Warrant seller in Q3 2023 was Wolverine Asset Management, an estimated $26K sold.

Based on aggregated 13F filings for Q3 2023.